Telomeres, Telomerase, and Cancer
- 27 April 2000
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (17) , 1282-1283
- https://doi.org/10.1056/nejm200004273421710
Abstract
What accounts for the ability of cancer cells to proliferate in a manner that is out of control, whereas normal cells die after 40 to 60 cycles of replication? One mechanism that leads to the death of a normal cell is erosion of the structure that caps the ends of chromosomes — the telomere (from the Greek telos, meaning end, and meros, a component) — each time a cell divides. The clinical relevance of telomeres is that a cancer cell, unlike a normal cell, can repair eroded telomeres. The existence of this repair mechanism suggests a novel target for cancer . . .Keywords
This publication has 5 references indexed in Scilit:
- Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene DeliveryScience, 2000
- Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapseBritish Journal of Cancer, 2000
- Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell deathProceedings of the National Academy of Sciences, 1999
- Inhibition of telomerase limits the growth of human cancer cellsNature Medicine, 1999
- Telomere shortening and apoptosis in telomerase-inhibited human tumor cellsGenes & Development, 1999